Abstract: Disclosed is a reversible ring for male urethral compression, which comprises a semicircular base (1) formed by a case and a cover of same, wherein the base (1) includes a locking tab (2), anti-slip imprints (3) and a flat belt (4) covered by a padded ring (7), a probe-holding clamp (5) being attached thereto, which is connected to the base (1) by means of a rod (6). The reversible ring is designed for carrying out (simply) both conventional retrograde urethrography (RUG) and new imaging techniques: urethrosonography (USG), urethro-computed tomography (urethro-CT) and urethro-magnetic resonance imaging (urethro-MRI), allowing the retrograde instillation of various radiological contrasts into the male urethra and bladder.

Abstract: The present invention aims to generate a fibrin gel for cell proliferation and transport using the patient's own blood or compatible blood. The gel-preparation process consists in taking a quantity of blood from the patient, using sodium citrate as anticoagulant, separating off the citrated plasma by centrifugation, and resuspending the cells to be transported in the plasma. CaCl2 is added to the resulting suspension to form the gel (either as an isolated coagulate or within a porous chitosan, gelatin or hyaluronic acid matrix), and the gel is cultured in an incubator to promote cell growth. The invention will be of use in cell growth for the purposes of implantation in cutaneous, cartilaginous, gingival and bone lesions, inter alias, and in the field of tissue engineering.

Abstract: New cycloalkanedione derivatives that are serotonin (5-hydroxytriptamine, 5-HT) 5-HT1A receptor subtype agonists and, consequently, they are useful in the treatment of pathological states for which an agonist of these receptors is indicated. They are particularly useful as neuroprotective agents, of special interest in the treatment and prophylaxis of cerebral damage produced by traumatic or ischemic stroke.

Abstract: The present invention is directed to substituted pyrimidine compounds of formula (I): and forms thereof, their synthesis and use for treating a chronic or acute protein kinase mediated disease, disorder or condition.

Abstract: New cycloalkanedione derivatives that are serotonin (5-hydroxytriptamine, 5-HT) 5-HT1A receptor subtype agonists and, consequently, they are useful in the treatment of pathological states for which an agonist of these receptors is indicated. They are particularly useful as neuroprotective agents, of special interest in the treatment and prophylaxis of cerebral damage produced by traumatic or ischemic stroke.

Abstract: A device for processing accounts data comprises i) a supervision module (9) provided with a memory (10) storing identification data for local terminals, each terminal being provided with local accounting software delivering detailed accounts data in a local format and accompanied by identification data and which can receive detailed local accounts data and identification data transmitted by the local terminals over a telecommunications network, and which can communicate the detailed local accounts data when accompanied by identification data stored in the memory (10); and ii) an interface module (11) that can convert detailed local accounts data communicated by the supervision module (9) into detailed local accounts data in the format of a database (4) with a view to memorising them in a selected first local zone (12) of the database.